PMCB: PharmaCyte Biotech, Inc. Stock

by  •  • Comments Off on PMCB: PharmaCyte Biotech, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 7.21
Enterprise Value ($M) -9.18
Book Value ($M) 40.25
Book Value / Share 5.86
Price / Book 0.18
NCAV ($M) 13.39
NCAV / Share 1.95
Price / NCAV 0.54

Profitability (mra)
Return on Invested Capital (ROIC) 0.50
Return on Assets (ROA) 0.34
Return on Equity (ROE) 0.45

Liquidity (mrq)
Quick Ratio 14.20
Current Ratio 14.20

Balance Sheet (mrq) ($M)
Current Assets 16.96
Assets 43.83
Liabilities 3.58
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Ayrton Capital LLC 9.90 -19.05
11-13 13G/A Intracoastal Capital, Llc 9.99 -12.14

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-12-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-09-17 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 96 4,385 2.19
2025-05-12 604 10,223 5.91
2025-05-09 1,061 6,655 15.94
2025-05-08 1,415 4,376 32.34

(click for more detail)

Similar Companies
PDSB – PDS Biotechnology Corporation PHIO – Phio Pharmaceuticals Corp.
PLUR – Pluri Inc. PMN – ProMIS Neurosciences, Inc.
PRFX – PainReform Ltd.


Financial data and stock pages provided by
Fintel.io